CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 86 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2020. The put-call ratio across all filers is 0.18 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $34,000 | 0.0% | 285 | 0.0% | 0.00% | – |
Q4 2020 | $34,000 | +78.9% | 285 | +70.7% | 0.00% | – |
Q3 2020 | $19,000 | +850.0% | 167 | +659.1% | 0.00% | – |
Q1 2020 | $2,000 | -100.0% | 22 | -100.0% | 0.00% | -100.0% |
Q3 2019 | $8,011,000 | +496.9% | 69,986 | +397.1% | 0.06% | +441.7% |
Q2 2019 | $1,342,000 | +886.8% | 14,078 | +842.9% | 0.01% | +500.0% |
Q1 2019 | $136,000 | -83.4% | 1,493 | -86.2% | 0.00% | -71.4% |
Q4 2018 | $820,000 | – | 10,808 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Maso Capital Partners Ltd | 627,111 | $74,068,000 | 20.20% |
Athos Capital Ltd | 362,909 | $42,863,000 | 11.81% |
PSquared Asset Management AG | 205,000 | $24,213,000 | 3.85% |
York Capital Management Global Advisors, LLC | 302,675 | $35,749,000 | 3.52% |
HHLR ADVISORS, LTD. | 2,962,076 | $349,851,000 | 2.78% |
ALPINE ASSOCIATES MANAGEMENT INC. | 534,180 | $63,092,000 | 2.58% |
Pentwater Capital Management LP | 1,178,000 | $139,134,000 | 1.68% |
Temasek Holdings (Private) Ltd | 1,240,000 | $146,456,000 | 0.63% |
AQR Arbitrage LLC | 142,733 | $16,858,000 | 0.59% |
FORT, L.P. | 9,761 | $1,153,000 | 0.34% |